NCT03089554: Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- State
- Under way
- Phase
- Phase 2
- People
- 93 planned
- Started
- 11 Apr 2017
- Primary completion
- Apr 2027
- Arms
- Therapeutic Intervention
- Results
- None posted
- 24 Mar 2017: Trial registered
- 11 Apr 2017: Trial started